Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin vs Heparin-Aspirin in Free Flap Surgery
NCT06512233Not yet recruiting
- Sponsor
- Aga Khan University
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of aspirin in thrombosis (2 arms), sponsored by Aga Khan University. Primary endpoint: Free Flap Survival Rate at 72 hours. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT06512233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06512233.